miRNA-155 Assay Before and After Immunotherapy and Probiotics

• Status: Completed
• Trial end date: 2019-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators aimed to explore miRNA-155 change in response to sublingual immunotherapy (SLIT), probiotics and combined treatment with SLIT and probiotics in AR children.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zagazig University
• Treatments: Calcium Carbonate

Criteria

Inclusion Criteria:

• Children aged 5-18 years

• Diagnosed as having AR

• With positive skin test to grass pollen

Exclusion Criteria:

• Anatomical abnormalities of upper respiratory tract,

• Previous immunotherapy,

• Clinically significant inflammatory diseases,

• Malignancies,

• Chronic treatment with systemic corticosteroids or immune suppressive drugs